Novavax Trivalent Seasonal Influenza VLP Vaccine (Recombinant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novavax Trivalent Seasonal Influenza VLP Vaccine (Recombinant), covering 2013-07-18 to 2013-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) [Phase 2]